Study on the effect of miR-29 on cisplatin resistance of ovarian cancer
博士 === 國防醫學院 === 醫學科學研究所 === 102 === Epithelial ovarian cancer (EOC) is a common gynecologic malignancy and is one of the 10 most common causes of death by cancer in women. Drug resistance is an obstacle to the treatment of ovarian cancer. Using a unique cell model, we have proven previously that a...
Main Authors: | Pei-Ning Yu, 游珮寧 |
---|---|
Other Authors: | Ya-Wen Lin |
Format: | Others |
Language: | en_US |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/01396477385001012040 |
Similar Items
-
miR-4461 Regulates the Proliferation and Metastasis of Ovarian Cancer Cells and Cisplatin Resistance
by: Lei Dou, et al.
Published: (2021-03-01) -
HOTTIP-miR-205-ZEB2 Axis Confers Cisplatin Resistance to Ovarian Cancer Cells
by: Yu-Jie Dong, et al.
Published: (2021-07-01) -
MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells.
by: Ningwei Li, et al.
Published: (2015-01-01) -
miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
by: Feng X, et al.
Published: (2017-12-01) -
LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer
by: Jiang X, et al.
Published: (2021-05-01)